ClinicalTrials.gg
CompletedNCT05752266Updated Nov 29, 2024

Effect of Probiotics on Amino Acid Absorption

An interventional study of AMILI Probiotic pills and Placebo pills in Protein Digestion and Gastrointestinal Microbiome, sponsored by Singapore Institute of Technology. Completed at 1 site in Singapore. Open to participants aged 21 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-11-29.

Sponsored by Singapore Institute of Technology · Not applicable, Interventional, and Basic science

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
21 Years to 40 Years
Sex
All
01

Study summary

The goal of this clinical trial is to test effects of consuming probiotics in healthy adults. The main question it aims to answer is:

  • Do consuming probiotics affect a healthy adult's ability to absorb amino acids from plant proteins?

Participants will

  • Consume one dose of probiotic pills per day after meals for two weeks
  • Consume one dose of plant-based plant protein beverage after an overnight fast and collection of one 5 ml fasting blood sample
  • Undergo blood draw of 6 more 5 ml blood samples for the next 3 hours after consuming plant-based protein beverage
Read the detailed description

There is increasing evidence that the gut microbiota contributes to a range of immune, inflammatory, and metabolic responses. Numerous studies have shown that administrating probiotics - strains of bacteria that benefits intestinal function - confer benefits to the host's immune system. Except for soy protein, plant proteins are incomplete proteins lacking in one or more essential amino acids. The incomplete amino acid profile of most plant proteins is compounded by their lower rate of absorption as compared to animal protein. Hence, the investigators aim to investigate the administration of probiotics as a potential strategy to overcome compositional shortcomings of plant proteins by improving the gastrointestinal absorption of plant-based proteins.

The aim of Stage 1 is to formulate a plant-based protein beverage with optimized amino acid profile with consumer acceptance.

Stage 2 of this study will be to conduct a randomized, double-blind, placebo-controlled, crossover trial using the formulation developed in Stage 1, together with probiotics supplementation to evaluate the effect of probiotics on the absorption of amino acids from plant proteins.

The probiotics to be studied will be provided by the Asian Microbiome Library (AMILI) with the plant protein beverage to be developed within SIT. Findings from this mutually beneficial collaborative project with AMILI will pave the way to further understand the role of probiotics in human health, particularly its effect in nutrient absorption of plant protein.

02

Conditions studied

  • Protein Digestion
  • Gastrointestinal Microbiome
03

In context

Lead sponsor

Singapore Institute of Technology is the lead sponsor of 8 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Be willing and able to comply with study procedures and give written
  • Self-reported to be healthy
  • Within healthy weight range (18.5-23kg/m2)

Exclusion criteria

Exclusion Criteria:

  • Any chronic medical condition
  • Individuals who were treated for or diagnosed with a gastrointestinal, cardiac, respiratory, circulatory, musculoskeletal, metabolic, immune, , haematological, neurological or endocrinological disorder
  • Antibiotic use
  • Prebiotics, probiotics, synbiotics, and/or digestive enzymes use
  • Food allergy/intolerances/avoidances towards eggs, soya, peanuts, tree nuts, crustaceans, and gluten
  • Smoking
  • Alcohol consumption
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Autoimmune disease

A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.

Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Care provider)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    Probiotic Arm

    Participants allocated to PRO arm will be administered personalized probiotic pills.

    Dietary Supplement: AMILI Probiotic pills

  • Placebo comparator
    Placebo Arm

    Participants allocated to PRO arm will be administered maltodextrin placebo pills similar in appearance to probiotic pills.

    Dietary Supplement: Placebo pills

Interventions

  • Dietary supplementAMILI Probiotic pills

    AMILI (AMILI Pte Ltd) will analyze stool samples provided by participants, and assign each participant a type of probiotic pill from the 5 different types of probiotic pills commercially available in AMILI retail store.

  • Dietary supplementPlacebo pills

    Placebo pills contaning maltodextrin with similar appearance to Probiotic pills will be provided to participants allocated to the Placebo Arm.

06

What researchers measure

Primary outcomes

  1. Change in blood amino acid concentration

    Following ingestion of plant protein beverage, participants will be subjected to drawing of serial blood samples after consuming the plant protein beverage. These blood samples will be analyzed for amino acid profile using mass spectrometry methods.

    Time frame: 0 to 150 minutes after ingestion of plant protein beverage on each study visit

  2. Change in gut microbiota type

    Paricipants will provide a stool sample on each study visit (3 stool samples in total throughout the study). These stool samples given will be analyzed for any changes in type and population size of gut microbes of participants after probiotic intervention and placebo comparator intervention.

    Time frame: 0 to 6 weeks after start of study

  3. Change in gut microbiota population size

    Paricipants will provide a stool sample on each study visit (3 stool samples in total throughout the study). These stool samples given will be analyzed for any changes in type and population size of gut microbes of participants after probiotic intervention and placebo comparator intervention.

    Time frame: 0 to 6 weeks after start of study

Secondary outcomes

  1. Change in blood glucose level

    Following ingestion of plant protein beverage, participants will be subjected to drawing of serial blood samples after consuming the plant protein beverage. Serial blood samples will be analyzed for glucose profile using mass spectrometry methods.

    Time frame: 0 to 150 minutes after ingestion of plant protein beverage

  2. Change in blood insulin level

    Following ingestion of plant protein beverage, participants will be subjected to drawing of serial blood samples after consuming the plant protein beverage. Serial blood samples will be analyzed for insulin profile using mass spectrometry methods.

    Time frame: 0 to 150 minutes after ingestion of plant protein beverage

07

Study locations

1 site
  • Verena Tan
    Singapore, Sinagpore 138683, Singapore
08

References and documents

Publications

  • Jager R, Zaragoza J, Purpura M, Iametti S, Marengo M, Tinsley GM, Anzalone AJ, Oliver JM, Fiore W, Biffi A, Urbina S, Taylor L. Probiotic Administration Increases Amino Acid Absorption from Plant Protein: a Placebo-Controlled, Randomized, Double-Blind, Multicenter, Crossover Study. Probiotics Antimicrob Proteins. 2020 Dec;12(4):1330-1339. doi: 10.1007/s12602-020-09656-5. PubMed 32358640 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Mar 2023 to primary completion in Jul 2023, 3 months.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 17, 2023
First posted
Mar 2, 2023
StartActual
Mar 27, 2023
Primary completionActual
Jul 14, 2023
CompletionActual
Sep 30, 2024
Last update
Nov 29, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 29, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05752266
Lead sponsor
Singapore Institute of Technology
Collaborators
AMILI Pte. Ltd.
Responsible party
Verena Tan Ming Hui (Associate Professor, Singapore Institute of Technology) — Principal investigator
First posted
Mar 2, 2023
Start date
Mar 27, 2023
Primary completion
Jul 14, 2023
Completion
Sep 30, 2024
Last update
Nov 29, 2024

Study contacts

Verena Tan, M.Nutr.Diet
principal investigator · +65 9172 4062

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion